[{"edinetCode":"E00957","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":769.0,"averageTemporaryStaff":165.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1842000.0,"sharesOwendPercent":0.4322,"outstandingShares":null,"numberOfSubsidiary":4.0,"bps":4548.8,"equityRatio":0.369,"cashAndCashEquivalents":8084000000.0,"assets":47002000000.0,"currentAssets":29009000000.0,"fixedAsset":17991000000.0,"tangibleFixedAssets":14707000000.0,"intangibleFixedAssets":66000000.0,"investmentAndOtherAssets":3217000000.0,"liabilities":29646000000.0,"currentLiabilities":14939000000.0,"shorTermDept":496000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2371000000.0,"fixedLiabilities":14706000000.0,"bonds":200000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":11737000000.0,"netAsset":17355000000.0,"capitalStock":14243000000.0,"capital":4304000000.0,"capitalSurplus":1303000000.0,"accumulatedEarnings":10702000000.0,"treasuryStock":-2066000000.0,"valuationAndConversionAdjustments":3102000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":35689000000.0,"costOfSales":19448000000.0,"grossProfit":16240000000.0,"sgaExpenses":13403000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1984000000.0,"operatingIncome":2836000000.0,"nonOperatingIncome":199000000.0,"nonOperatingExpenses":186000000.0,"interestExpense":136000000.0,"ordinaryProfit":2849000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":2849000000.0,"incomeTaxes":795000000.0,"netIncome":2054000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2054000000.0,"comprehensiveIncome":2196000000.0,"eps":530.02,"dilutedEps":529.91,"dividendPerShare":null,"per":10.0,"roe":0.123,"cashFlowFromOperatingActivities":2737000000.0,"depreciationAndCashflowFromOperatingActivities":1112000000.0,"cashFlowFromInvestingActivities":-2504000000.0,"cashFlowFromFinancialActivities":787000000.0,"changesInCashAndCashEquivalents":949000000.0,"列1":"asr","submitDate":"2017\/6\/26","stockCode":4539,"accountingYear":"第85期(自　平成28年４月１日　至　平成29年３月31日)","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00957","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4304,"settlementDate":"2022\/3\/31","submitterName":"日本ケミファ株式会社","submitterNameEnglish":"NIPPON CHEMIPHAR CO., LTD.","submitterNameKana":"ニッポンケミファカブシキガイシャ","location":"千代田区岩本町二丁目２番３号","industory":"医薬品","corporateNumber":5010000000000.0},{"edinetCode":"E00957","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":816.0,"averageTemporaryStaff":176.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1709000.0,"sharesOwendPercent":0.4698,"outstandingShares":null,"numberOfSubsidiary":4.0,"bps":4859.86,"equityRatio":0.373,"cashAndCashEquivalents":7890000000.0,"assets":46814000000.0,"currentAssets":28334000000.0,"fixedAsset":18479000000.0,"tangibleFixedAssets":14549000000.0,"intangibleFixedAssets":251000000.0,"investmentAndOtherAssets":3678000000.0,"liabilities":29326000000.0,"currentLiabilities":14914000000.0,"shorTermDept":476000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2455000000.0,"fixedLiabilities":14412000000.0,"bonds":200000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":11546000000.0,"netAsset":17487000000.0,"capitalStock":14019000000.0,"capital":4304000000.0,"capitalSurplus":1303000000.0,"accumulatedEarnings":11596000000.0,"treasuryStock":-3185000000.0,"valuationAndConversionAdjustments":3454000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":35331000000.0,"costOfSales":19535000000.0,"grossProfit":15795000000.0,"sgaExpenses":13947000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":2280000000.0,"operatingIncome":1848000000.0,"nonOperatingIncome":132000000.0,"nonOperatingExpenses":284000000.0,"interestExpense":133000000.0,"ordinaryProfit":1696000000.0,"extraordinaryGain":80000000.0,"extraordinaryLoss":null,"incomeBeforeTax":1777000000.0,"incomeTaxes":616000000.0,"netIncome":1160000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1160000000.0,"comprehensiveIncome":1631000000.0,"eps":315.28,"dilutedEps":null,"dividendPerShare":null,"per":15.0,"roe":0.067,"cashFlowFromOperatingActivities":3188000000.0,"depreciationAndCashflowFromOperatingActivities":1192000000.0,"cashFlowFromInvestingActivities":-1606000000.0,"cashFlowFromFinancialActivities":-1741000000.0,"changesInCashAndCashEquivalents":-194000000.0,"列1":"asr","submitDate":"2018\/6\/25","stockCode":4539,"accountingYear":"第86期(自　平成29年４月１日　至　平成30年３月31日)","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00957","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4304,"settlementDate":"2022\/3\/31","submitterName":"日本ケミファ株式会社","submitterNameEnglish":"NIPPON CHEMIPHAR CO., LTD.","submitterNameKana":"ニッポンケミファカブシキガイシャ","location":"千代田区岩本町二丁目２番３号","industory":"医薬品","corporateNumber":5010000000000.0},{"edinetCode":"E00957","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":846.0,"averageTemporaryStaff":193.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1726000.0,"sharesOwendPercent":0.4746,"outstandingShares":null,"numberOfSubsidiary":4.0,"bps":4963.24,"equityRatio":0.38,"cashAndCashEquivalents":9254000000.0,"assets":46926000000.0,"currentAssets":28668000000.0,"fixedAsset":18256000000.0,"tangibleFixedAssets":13790000000.0,"intangibleFixedAssets":375000000.0,"investmentAndOtherAssets":4089000000.0,"liabilities":29063000000.0,"currentLiabilities":13825000000.0,"shorTermDept":432000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2495000000.0,"fixedLiabilities":15237000000.0,"bonds":200000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":12158000000.0,"netAsset":17863000000.0,"capitalStock":14535000000.0,"capital":4304000000.0,"capitalSurplus":1303000000.0,"accumulatedEarnings":12113000000.0,"treasuryStock":-3187000000.0,"valuationAndConversionAdjustments":3308000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":34182000000.0,"costOfSales":19655000000.0,"grossProfit":14526000000.0,"sgaExpenses":13063000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":2066000000.0,"operatingIncome":1464000000.0,"nonOperatingIncome":225000000.0,"nonOperatingExpenses":177000000.0,"interestExpense":129000000.0,"ordinaryProfit":1512000000.0,"extraordinaryGain":null,"extraordinaryLoss":58000000.0,"incomeBeforeTax":1454000000.0,"incomeTaxes":572000000.0,"netIncome":881000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":881000000.0,"comprehensiveIncome":735000000.0,"eps":245.11,"dilutedEps":null,"dividendPerShare":null,"per":11.9,"roe":0.05,"cashFlowFromOperatingActivities":2196000000.0,"depreciationAndCashflowFromOperatingActivities":1345000000.0,"cashFlowFromInvestingActivities":-960000000.0,"cashFlowFromFinancialActivities":110000000.0,"changesInCashAndCashEquivalents":1364000000.0,"列1":"asr","submitDate":"2019\/6\/24","stockCode":4539,"accountingYear":"第87期(自　2018年４月１日　至　2019年３月31日)","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00957","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4304,"settlementDate":"2022\/3\/31","submitterName":"日本ケミファ株式会社","submitterNameEnglish":"NIPPON CHEMIPHAR CO., LTD.","submitterNameKana":"ニッポンケミファカブシキガイシャ","location":"千代田区岩本町二丁目２番３号","industory":"医薬品","corporateNumber":5010000000000.0},{"edinetCode":"E00957","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.37,"cashAndCashEquivalents":null,"assets":48588000000.0,"currentAssets":30501000000.0,"fixedAsset":18086000000.0,"tangibleFixedAssets":13591000000.0,"intangibleFixedAssets":363000000.0,"investmentAndOtherAssets":4131000000.0,"liabilities":30585000000.0,"currentLiabilities":15247000000.0,"shorTermDept":1000000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2579000000.0,"fixedLiabilities":15337000000.0,"bonds":200000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":12356000000.0,"netAsset":18003000000.0,"capitalStock":14591000000.0,"capital":4304000000.0,"capitalSurplus":1303000000.0,"accumulatedEarnings":12170000000.0,"treasuryStock":-3187000000.0,"valuationAndConversionAdjustments":3390000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":8304000000.0,"costOfSales":4598000000.0,"grossProfit":3705000000.0,"sgaExpenses":3039000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":408000000.0,"operatingIncome":666000000.0,"nonOperatingIncome":36000000.0,"nonOperatingExpenses":106000000.0,"interestExpense":30000000.0,"ordinaryProfit":596000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":596000000.0,"incomeTaxes":176000000.0,"netIncome":420000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":420000000.0,"comprehensiveIncome":502000000.0,"eps":116.89,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/8","stockCode":4539,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00957","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4304,"settlementDate":"2022\/3\/31","submitterName":"日本ケミファ株式会社","submitterNameEnglish":"NIPPON CHEMIPHAR CO., LTD.","submitterNameKana":"ニッポンケミファカブシキガイシャ","location":"千代田区岩本町二丁目２番３号","industory":"医薬品","corporateNumber":5010000000000.0},{"edinetCode":"E00957","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1698000.0,"sharesOwendPercent":0.4667,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.375,"cashAndCashEquivalents":10649000000.0,"assets":47322000000.0,"currentAssets":29693000000.0,"fixedAsset":17627000000.0,"tangibleFixedAssets":13386000000.0,"intangibleFixedAssets":346000000.0,"investmentAndOtherAssets":3895000000.0,"liabilities":29562000000.0,"currentLiabilities":13651000000.0,"shorTermDept":544000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2664000000.0,"fixedLiabilities":15910000000.0,"bonds":200000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":12760000000.0,"netAsset":17759000000.0,"capitalStock":14497000000.0,"capital":4304000000.0,"capitalSurplus":1303000000.0,"accumulatedEarnings":12076000000.0,"treasuryStock":-3187000000.0,"valuationAndConversionAdjustments":3239000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":16097000000.0,"costOfSales":9220000000.0,"grossProfit":6876000000.0,"sgaExpenses":6257000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1112000000.0,"operatingIncome":619000000.0,"nonOperatingIncome":55000000.0,"nonOperatingExpenses":161000000.0,"interestExpense":62000000.0,"ordinaryProfit":513000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":513000000.0,"incomeTaxes":187000000.0,"netIncome":326000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":326000000.0,"comprehensiveIncome":257000000.0,"eps":90.83,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1161000000.0,"depreciationAndCashflowFromOperatingActivities":614000000.0,"cashFlowFromInvestingActivities":-214000000.0,"cashFlowFromFinancialActivities":470000000.0,"changesInCashAndCashEquivalents":1394000000.0,"列1":"q2r","submitDate":"2019\/11\/13","stockCode":4539,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00957","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4304,"settlementDate":"2022\/3\/31","submitterName":"日本ケミファ株式会社","submitterNameEnglish":"NIPPON CHEMIPHAR CO., LTD.","submitterNameKana":"ニッポンケミファカブシキガイシャ","location":"千代田区岩本町二丁目２番３号","industory":"医薬品","corporateNumber":5010000000000.0},{"edinetCode":"E00957","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.375,"cashAndCashEquivalents":null,"assets":47545000000.0,"currentAssets":30672000000.0,"fixedAsset":16871000000.0,"tangibleFixedAssets":13250000000.0,"intangibleFixedAssets":342000000.0,"investmentAndOtherAssets":3278000000.0,"liabilities":29702000000.0,"currentLiabilities":14284000000.0,"shorTermDept":640000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2588000000.0,"fixedLiabilities":15418000000.0,"bonds":200000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":12289000000.0,"netAsset":17843000000.0,"capitalStock":14838000000.0,"capital":4304000000.0,"capitalSurplus":1303000000.0,"accumulatedEarnings":12417000000.0,"treasuryStock":-3187000000.0,"valuationAndConversionAdjustments":2980000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":24266000000.0,"costOfSales":14417000000.0,"grossProfit":9849000000.0,"sgaExpenses":9222000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1625000000.0,"operatingIncome":627000000.0,"nonOperatingIncome":82000000.0,"nonOperatingExpenses":163000000.0,"interestExpense":94000000.0,"ordinaryProfit":546000000.0,"extraordinaryGain":442000000.0,"extraordinaryLoss":null,"incomeBeforeTax":989000000.0,"incomeTaxes":321000000.0,"netIncome":667000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":667000000.0,"comprehensiveIncome":339000000.0,"eps":185.68,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/13","stockCode":4539,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00957","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4304,"settlementDate":"2022\/3\/31","submitterName":"日本ケミファ株式会社","submitterNameEnglish":"NIPPON CHEMIPHAR CO., LTD.","submitterNameKana":"ニッポンケミファカブシキガイシャ","location":"千代田区岩本町二丁目２番３号","industory":"医薬品","corporateNumber":5010000000000.0},{"edinetCode":"E00957","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":807.0,"averageTemporaryStaff":196.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1776000.0,"sharesOwendPercent":0.4881,"outstandingShares":null,"numberOfSubsidiary":4.0,"bps":4830.92,"equityRatio":0.379,"cashAndCashEquivalents":10000000000.0,"assets":45862000000.0,"currentAssets":29314000000.0,"fixedAsset":16547000000.0,"tangibleFixedAssets":13185000000.0,"intangibleFixedAssets":324000000.0,"investmentAndOtherAssets":3037000000.0,"liabilities":28470000000.0,"currentLiabilities":13739000000.0,"shorTermDept":400000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2660000000.0,"fixedLiabilities":14730000000.0,"bonds":200000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":11537000000.0,"netAsset":17392000000.0,"capitalStock":14607000000.0,"capital":4304000000.0,"capitalSurplus":1303000000.0,"accumulatedEarnings":12186000000.0,"treasuryStock":-3187000000.0,"valuationAndConversionAdjustments":2759000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":31756000000.0,"costOfSales":19202000000.0,"grossProfit":12554000000.0,"sgaExpenses":12190000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":2173000000.0,"operatingIncome":364000000.0,"nonOperatingIncome":152000000.0,"nonOperatingExpenses":210000000.0,"interestExpense":124000000.0,"ordinaryProfit":307000000.0,"extraordinaryGain":475000000.0,"extraordinaryLoss":49000000.0,"incomeBeforeTax":732000000.0,"incomeTaxes":296000000.0,"netIncome":436000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":436000000.0,"comprehensiveIncome":-112000000.0,"eps":121.42,"dilutedEps":null,"dividendPerShare":null,"per":20.4,"roe":0.025,"cashFlowFromOperatingActivities":1394000000.0,"depreciationAndCashflowFromOperatingActivities":1272000000.0,"cashFlowFromInvestingActivities":326000000.0,"cashFlowFromFinancialActivities":-961000000.0,"changesInCashAndCashEquivalents":745000000.0,"列1":"asr","submitDate":"2020\/6\/22","stockCode":4539,"accountingYear":"第88期(自　2019年４月１日　至　2020年３月31日)","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00957","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4304,"settlementDate":"2022\/3\/31","submitterName":"日本ケミファ株式会社","submitterNameEnglish":"NIPPON CHEMIPHAR CO., LTD.","submitterNameKana":"ニッポンケミファカブシキガイシャ","location":"千代田区岩本町二丁目２番３号","industory":"医薬品","corporateNumber":5010000000000.0},{"edinetCode":"E00957","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.363,"cashAndCashEquivalents":null,"assets":47705000000.0,"currentAssets":30443000000.0,"fixedAsset":17260000000.0,"tangibleFixedAssets":12674000000.0,"intangibleFixedAssets":1377000000.0,"investmentAndOtherAssets":3208000000.0,"liabilities":30380000000.0,"currentLiabilities":14376000000.0,"shorTermDept":790000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2806000000.0,"fixedLiabilities":16003000000.0,"bonds":200000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":12926000000.0,"netAsset":17324000000.0,"capitalStock":14600000000.0,"capital":4304000000.0,"capitalSurplus":1303000000.0,"accumulatedEarnings":12180000000.0,"treasuryStock":-3187000000.0,"valuationAndConversionAdjustments":2697000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":7196000000.0,"costOfSales":4640000000.0,"grossProfit":2555000000.0,"sgaExpenses":2589000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":477000000.0,"operatingIncome":-32000000.0,"nonOperatingIncome":24000000.0,"nonOperatingExpenses":60000000.0,"interestExpense":30000000.0,"ordinaryProfit":-68000000.0,"extraordinaryGain":56000000.0,"extraordinaryLoss":null,"incomeBeforeTax":-12000000.0,"incomeTaxes":-31000000.0,"netIncome":19000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":19000000.0,"comprehensiveIncome":112000000.0,"eps":5.45,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/11","stockCode":4539,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00957","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4304,"settlementDate":"2022\/3\/31","submitterName":"日本ケミファ株式会社","submitterNameEnglish":"NIPPON CHEMIPHAR CO., LTD.","submitterNameKana":"ニッポンケミファカブシキガイシャ","location":"千代田区岩本町二丁目２番３号","industory":"医薬品","corporateNumber":5010000000000.0},{"edinetCode":"E00957","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1793000.0,"sharesOwendPercent":0.4928,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.364,"cashAndCashEquivalents":10750000000.0,"assets":46933000000.0,"currentAssets":29859000000.0,"fixedAsset":17072000000.0,"tangibleFixedAssets":12476000000.0,"intangibleFixedAssets":1363000000.0,"investmentAndOtherAssets":3233000000.0,"liabilities":29846000000.0,"currentLiabilities":13982000000.0,"shorTermDept":460000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2768000000.0,"fixedLiabilities":15863000000.0,"bonds":200000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":12827000000.0,"netAsset":17087000000.0,"capitalStock":14323000000.0,"capital":4304000000.0,"capitalSurplus":1303000000.0,"accumulatedEarnings":11903000000.0,"treasuryStock":-3187000000.0,"valuationAndConversionAdjustments":2746000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":14832000000.0,"costOfSales":9447000000.0,"grossProfit":5385000000.0,"sgaExpenses":5575000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1113000000.0,"operatingIncome":-189000000.0,"nonOperatingIncome":97000000.0,"nonOperatingExpenses":152000000.0,"interestExpense":62000000.0,"ordinaryProfit":-245000000.0,"extraordinaryGain":66000000.0,"extraordinaryLoss":167000000.0,"incomeBeforeTax":-346000000.0,"incomeTaxes":-88000000.0,"netIncome":-257000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-257000000.0,"comprehensiveIncome":-115000000.0,"eps":-71.6,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":428000000.0,"depreciationAndCashflowFromOperatingActivities":689000000.0,"cashFlowFromInvestingActivities":-877000000.0,"cashFlowFromFinancialActivities":1221000000.0,"changesInCashAndCashEquivalents":750000000.0,"列1":"q2r","submitDate":"2020\/11\/13","stockCode":4539,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00957","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4304,"settlementDate":"2022\/3\/31","submitterName":"日本ケミファ株式会社","submitterNameEnglish":"NIPPON CHEMIPHAR CO., LTD.","submitterNameKana":"ニッポンケミファカブシキガイシャ","location":"千代田区岩本町二丁目２番３号","industory":"医薬品","corporateNumber":5010000000000.0},{"edinetCode":"E00957","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.364,"cashAndCashEquivalents":null,"assets":48059000000.0,"currentAssets":31611000000.0,"fixedAsset":16447000000.0,"tangibleFixedAssets":12244000000.0,"intangibleFixedAssets":1319000000.0,"investmentAndOtherAssets":2882000000.0,"liabilities":30571000000.0,"currentLiabilities":14954000000.0,"shorTermDept":600000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2675000000.0,"fixedLiabilities":15616000000.0,"bonds":200000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":12387000000.0,"netAsset":17488000000.0,"capitalStock":14916000000.0,"capital":4304000000.0,"capitalSurplus":1303000000.0,"accumulatedEarnings":12495000000.0,"treasuryStock":-3187000000.0,"valuationAndConversionAdjustments":2554000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":23612000000.0,"costOfSales":14855000000.0,"grossProfit":8756000000.0,"sgaExpenses":8296000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1565000000.0,"operatingIncome":460000000.0,"nonOperatingIncome":120000000.0,"nonOperatingExpenses":258000000.0,"interestExpense":93000000.0,"ordinaryProfit":321000000.0,"extraordinaryGain":282000000.0,"extraordinaryLoss":167000000.0,"incomeBeforeTax":436000000.0,"incomeTaxes":101000000.0,"netIncome":335000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":335000000.0,"comprehensiveIncome":285000000.0,"eps":93.3,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/12","stockCode":4539,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00957","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4304,"settlementDate":"2022\/3\/31","submitterName":"日本ケミファ株式会社","submitterNameEnglish":"NIPPON CHEMIPHAR CO., LTD.","submitterNameKana":"ニッポンケミファカブシキガイシャ","location":"千代田区岩本町二丁目２番３号","industory":"医薬品","corporateNumber":5010000000000.0},{"edinetCode":"E00957","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":760.0,"averageTemporaryStaff":168.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1804000.0,"sharesOwendPercent":0.496,"outstandingShares":null,"numberOfSubsidiary":4.0,"bps":5006.49,"equityRatio":0.382,"cashAndCashEquivalents":10505000000.0,"assets":47124000000.0,"currentAssets":30446000000.0,"fixedAsset":16676000000.0,"tangibleFixedAssets":12309000000.0,"intangibleFixedAssets":1242000000.0,"investmentAndOtherAssets":3124000000.0,"liabilities":29109000000.0,"currentLiabilities":14102000000.0,"shorTermDept":384000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2420000000.0,"fixedLiabilities":15006000000.0,"bonds":200000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":12114000000.0,"netAsset":18014000000.0,"capitalStock":15076000000.0,"capital":4304000000.0,"capitalSurplus":1303000000.0,"accumulatedEarnings":12655000000.0,"treasuryStock":-3187000000.0,"valuationAndConversionAdjustments":2921000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":31541000000.0,"costOfSales":20097000000.0,"grossProfit":11443000000.0,"sgaExpenses":10879000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1998000000.0,"operatingIncome":564000000.0,"nonOperatingIncome":172000000.0,"nonOperatingExpenses":154000000.0,"interestExpense":122000000.0,"ordinaryProfit":582000000.0,"extraordinaryGain":299000000.0,"extraordinaryLoss":167000000.0,"incomeBeforeTax":713000000.0,"incomeTaxes":218000000.0,"netIncome":495000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":495000000.0,"comprehensiveIncome":812000000.0,"eps":137.75,"dilutedEps":null,"dividendPerShare":null,"per":19.1,"roe":0.028,"cashFlowFromOperatingActivities":1503000000.0,"depreciationAndCashflowFromOperatingActivities":1393000000.0,"cashFlowFromInvestingActivities":-1024000000.0,"cashFlowFromFinancialActivities":29000000.0,"changesInCashAndCashEquivalents":505000000.0,"列1":"asr","submitDate":"2021\/6\/21","stockCode":4539,"accountingYear":"第89期(自　2020年４月１日　至　2021年３月31日)","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00957","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4304,"settlementDate":"2022\/3\/31","submitterName":"日本ケミファ株式会社","submitterNameEnglish":"NIPPON CHEMIPHAR CO., LTD.","submitterNameKana":"ニッポンケミファカブシキガイシャ","location":"千代田区岩本町二丁目２番３号","industory":"医薬品","corporateNumber":5010000000000.0},{"edinetCode":"E00957","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.372,"cashAndCashEquivalents":null,"assets":48127000000.0,"currentAssets":31605000000.0,"fixedAsset":16520000000.0,"tangibleFixedAssets":12245000000.0,"intangibleFixedAssets":1155000000.0,"investmentAndOtherAssets":3119000000.0,"liabilities":30219000000.0,"currentLiabilities":14386000000.0,"shorTermDept":840000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2464000000.0,"fixedLiabilities":15832000000.0,"bonds":200000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":12959000000.0,"netAsset":17907000000.0,"capitalStock":14901000000.0,"capital":4304000000.0,"capitalSurplus":1303000000.0,"accumulatedEarnings":12480000000.0,"treasuryStock":-3187000000.0,"valuationAndConversionAdjustments":2989000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":7575000000.0,"costOfSales":5529000000.0,"grossProfit":2045000000.0,"sgaExpenses":2071000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":620000000.0,"operatingIncome":-26000000.0,"nonOperatingIncome":76000000.0,"nonOperatingExpenses":34000000.0,"interestExpense":29000000.0,"ordinaryProfit":15000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":15000000.0,"incomeTaxes":28000000.0,"netIncome":-13000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-13000000.0,"comprehensiveIncome":54000000.0,"eps":-3.66,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/11","stockCode":4539,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00957","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4304,"settlementDate":"2022\/3\/31","submitterName":"日本ケミファ株式会社","submitterNameEnglish":"NIPPON CHEMIPHAR CO., LTD.","submitterNameKana":"ニッポンケミファカブシキガイシャ","location":"千代田区岩本町二丁目２番３号","industory":"医薬品","corporateNumber":5010000000000.0},{"edinetCode":"E00957","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1935000.0,"sharesOwendPercent":0.5296,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.375,"cashAndCashEquivalents":11905000000.0,"assets":48530000000.0,"currentAssets":31850000000.0,"fixedAsset":16679000000.0,"tangibleFixedAssets":12286000000.0,"intangibleFixedAssets":1066000000.0,"investmentAndOtherAssets":3327000000.0,"liabilities":30326000000.0,"currentLiabilities":14575000000.0,"shorTermDept":480000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2425000000.0,"fixedLiabilities":15751000000.0,"bonds":200000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":12594000000.0,"netAsset":18203000000.0,"capitalStock":15180000000.0,"capital":4304000000.0,"capitalSurplus":1263000000.0,"accumulatedEarnings":12722000000.0,"treasuryStock":-3109000000.0,"valuationAndConversionAdjustments":3006000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":15575000000.0,"costOfSales":11265000000.0,"grossProfit":4309000000.0,"sgaExpenses":4103000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1188000000.0,"operatingIncome":206000000.0,"nonOperatingIncome":123000000.0,"nonOperatingExpenses":71000000.0,"interestExpense":60000000.0,"ordinaryProfit":258000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":258000000.0,"incomeTaxes":29000000.0,"netIncome":228000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":228000000.0,"comprehensiveIncome":313000000.0,"eps":63.56,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1473000000.0,"depreciationAndCashflowFromOperatingActivities":740000000.0,"cashFlowFromInvestingActivities":-576000000.0,"cashFlowFromFinancialActivities":340000000.0,"changesInCashAndCashEquivalents":1399000000.0,"列1":"q2r","submitDate":"2021\/11\/12","stockCode":4539,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00957","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4304,"settlementDate":"2022\/3\/31","submitterName":"日本ケミファ株式会社","submitterNameEnglish":"NIPPON CHEMIPHAR CO., LTD.","submitterNameKana":"ニッポンケミファカブシキガイシャ","location":"千代田区岩本町二丁目２番３号","industory":"医薬品","corporateNumber":5010000000000.0},{"edinetCode":"E00957","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.371,"cashAndCashEquivalents":null,"assets":50630000000.0,"currentAssets":34562000000.0,"fixedAsset":16068000000.0,"tangibleFixedAssets":11894000000.0,"intangibleFixedAssets":975000000.0,"investmentAndOtherAssets":3199000000.0,"liabilities":31807000000.0,"currentLiabilities":16602000000.0,"shorTermDept":640000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2403000000.0,"fixedLiabilities":15205000000.0,"bonds":200000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":12189000000.0,"netAsset":18823000000.0,"capitalStock":16190000000.0,"capital":4304000000.0,"capitalSurplus":1263000000.0,"accumulatedEarnings":13733000000.0,"treasuryStock":-3110000000.0,"valuationAndConversionAdjustments":2615000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":24727000000.0,"costOfSales":17642000000.0,"grossProfit":7085000000.0,"sgaExpenses":5985000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1602000000.0,"operatingIncome":1099000000.0,"nonOperatingIncome":226000000.0,"nonOperatingExpenses":174000000.0,"interestExpense":93000000.0,"ordinaryProfit":1152000000.0,"extraordinaryGain":141000000.0,"extraordinaryLoss":14000000.0,"incomeBeforeTax":1279000000.0,"incomeTaxes":326000000.0,"netIncome":952000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":952000000.0,"comprehensiveIncome":933000000.0,"eps":264.15,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/14","stockCode":4539,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00957","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4304,"settlementDate":"2022\/3\/31","submitterName":"日本ケミファ株式会社","submitterNameEnglish":"NIPPON CHEMIPHAR CO., LTD.","submitterNameKana":"ニッポンケミファカブシキガイシャ","location":"千代田区岩本町二丁目２番３号","industory":"医薬品","corporateNumber":5010000000000.0}]